Geographic Variation and Disparity in Stimulant Treatment of Adults and Children in the United States in 2008
Supplemental Material
1079_ds001.pdf (31 KB)
The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.
Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.
×1079_ds001.pdf (31 KB)
This study was supported by grant RC2 DA028920 awarded by the Office of the Director, National Institute on Drug Abuse. The authors thank Kenneth Carlson, A.B., David Izrael, M.S., Sarah Shoemaker, Pharm.D., Ph.D., Dana Hunt, Ph.D., and Jessica Levin, B.A., for assistance and advice. Prescription LRx Data for 2008 were obtained under license from IMS Health. County location of prescribers’ offices was obtained from Physician Professional Data for 2008 from the American Medical Association. The statements, findings, conclusions, views, and opinions contained and expressed herein do not necessarily represent the views or policies of Abt Associates, Inc., the National Institutes of Health, the National Institute on Drug Abuse, or IMS Health or any of its affiliated or subsidiary entities.
The authors report no competing interests.